Few questions. 1) why aren’t you using a CAPM for the cost of equity as it seems like some factors such as idiosyncratic risk and size premia are missing? Also the cost of debt to get the WACC. The 7.4% seems a bit low compared to the high on! growth / high assumed base case returns. 2)40% base case growth for on! products seems like an extreme bull case, no? 20% seems like a bull case even, given pouches were a big trend from ‘22–24. My co workers/ friends were big into Zyns during that timeframe but I’ve since seen them quit. 3)Younger Americans (18-30) would be more likely to convert to Juuls/nicotine pods than cigs in my opinion. I don’t see many people smoking cigs routinely, but I do commonly see people sneaking in a shameful Juul hit in public places. 4)Total debt is high, but coverage ratios are pretty goodish. What are the current maturities? Also what % of par are their bonds trading at? (You said this is a long term play but still a good indicator to see how much lower it could go). 5)Revenues have been declining since 2020 but net of excise tax they have barely increased? Was this due to a specific legislation? The current admin is beneficial to the tobacco industry but is a 14% excise tax a realistic projection? I do like the high div as that will incentivize long plays and gives the company an extra lever to pull incase on! doesn’t grow and the situation becomes distressed. This is well put together and very thorough. I really enjoyed reading this. Thank you.

---

BOJ hike, Espstein releases, $1.97 SPY Ex-Div payment, gov data gonna take us down to $669📉

---

the div is already insane

---

I agree!! My assumption is selling BTC will be the doomsday scenario, as that will cause immediate panic!! Other than that they only have the 1.4 Billion strategic reserve, to service 300M + interest & div obligations which is not a lot!!

---

you guys are sleeping on CMCSA 5 percent div crazy low PE and you get shares of versant in Jan

---